Llamas-Velasco M, Castañeda S, Sánchez-Pérez J, Vicente-Rabaneda EF, Pardo J, Cabeza-Martínez R, Miranda Fontes M, Márquez J, Calvo-Alén J, Armesto S, Belinchón I, Gómez A, Miranda MD, Martínez Pardo S, Merino L, Casado MA, Amaro A, Ordovás M, Yébenes M, Casado A
Cost of illness in patients with psoriasis and psoriatic arthritis disease. COEPSO Study
22nd Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Copenhague (Dinamarca). 2-6 nov 2019
Taxonera C, de Andrés-Nogales F, García S, Sánchez-Guerrero A, Menchen B, Peral C, Cábez A, Gómez S, López A, Casado MÁ, Menchén L
Cost-effectiveness of Tofacitinib for the Treatment of Moderate-to-severe Ulcerative Colitis After Conventional Therapy in Spain
22nd Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Copenhague (Dinamarca). 2-6 nov 2019
Menchén L, de Andrés-Nogales F, García S, Sánchez-Guerrero A, Menchen B, Cábez A, Gómez S, López A, Casado MÁ, Peral C, Taxonera C
Cost-effectivenes of Tofacitinib for the Treatment of Moderate-to-severe Ulcerative Colitis After Biologic Failure or Intolerance in Spain
22nd Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Copenhague (Dinamarca). 2-6 nov 2019
Puig L, Fernández-Freire LR, Burgos-Pol R, Gomez I, Peral C, Gomez S, Rebollo Laserna FJ
Economic Impact of Etanercept in Patients with Psoriasis and Psoriatic Arthritis in Spain: A Systematic Review
Dermatol Ther (Heidelb). doi: 10.1007/s13555-019-0301-6
Peral C, Balsa A, Pablos JL, Navarro F, Martínez-Sesmero JM, Montoro M, Gómez S, Valderrama M, de Andrés-Nogales F, Casado MA, Oyagüez I
Efficiency of treatment sequences containing tofacitinib for rheumatoid arthritis in Spain
European Congress of Rheumatology 2019 (EULAR). Madrid. 12-15 jun 2019
Peral C, Navarro F, Montoro M, Balsa A, Gomez S, Pablos J, Martinez-Sesmero JM, Valderrama M, Oyagüez I, de Andrés-Nogales F, Casado MÁ
Cost-effectiveness of tofacitinib-containing sequences for rheumatoid arthritis patients in Spain
21st Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Barcelona. 10-14 nov 2018
Llamas-Velasco M, Sánchez-Pérez J, Pardo J, Cabeza-Martínez R, Miranda Fontes M, Márquez J, Armesto S, Belinchón I, Castañeda S, Casado A, Amaro A, Yébenes M, Sabater E, COEPSO Study Group
Patient’s preferences for psoriasis treatment based on a discrete choice experiment. COEPSO study
21st Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Barcelona. 10-14 nov 2018
Castañeda S, Vicente-Rabaneda EF, Calvo-Alén J, Gómez A, Miranda MD, Martínez Pardo S, Merino L, Llamas-Velasco M, Casado A, Amaro A, Sabater E, Yébenes M, COEPSO Study Group
Patient’s preferences for treatment of psoriatic arthritis based on a discrete choice experiment. Results of the COEPSO study
21st Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Barcelona. 10-14 nov 2018
Peral C, Gomez I, Burgos R , Rebollo F